Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
DNA topoisomerase II (topo II) is involved in unlinking replicating DNA and organizing mitotic chromosomes. Topo II is the target of many antitumour drugs. Topo II inhibition results in extensive catenation of newly replicated DNA and may potentially perturb chromatin assembly. Here, we show that the topo II inhibitor ICRF-193 does not prevent the bulk of nucleosome deposition, but perturbs nucleosome spacing in Xenopus egg extracts. This is due to the trapping of topo II-closed clamps on the DNA rather than increased DNA catenation. Inhibition of replicative DNA decatenation has in itself little or no effect on nucleosome deposition and spacing, suggesting that DNA can easily accommodate the sharp bending constraints imposed by the co-habitation of nucleosomes and catenane nodes. Chromatin perturbation by topo II clamps may explain some dominant cellular effects of ICRF-193. Nucleosome-driven bending of precatenane nodes may facilitate their unlinking by topo II during unperturbed replication.
Almouzni,
Assembly of spaced chromatin involvement of ATP and DNA topoisomerase activity.
1988, Pubmed,
Xenbase
Almouzni,
Assembly of spaced chromatin involvement of ATP and DNA topoisomerase activity.
1988,
Pubmed
,
Xenbase
Almouzni,
Assembly of spaced chromatin promoted by DNA synthesis in extracts from Xenopus eggs.
1988,
Pubmed
,
Xenbase
Bakkenist,
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.
2003,
Pubmed
Buck,
DNA disentangling by type-2 topoisomerases.
2004,
Pubmed
Cloutier,
Spontaneous sharp bending of double-stranded DNA.
2004,
Pubmed
Downes,
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.
1994,
Pubmed
,
Xenbase
Du,
Cyclization of short DNA fragments and bending fluctuations of the double helix.
2005,
Pubmed
Gruss,
Disruption of the nucleosomes at the replication fork.
1993,
Pubmed
,
Xenbase
Jensen,
A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines.
2000,
Pubmed
Larsen,
Catalytic topoisomerase II inhibitors in cancer therapy.
2003,
Pubmed
Li,
Tumor cell death induced by topoisomerase-targeting drugs.
2001,
Pubmed
Lucas,
Topoisomerase II can unlink replicating DNA by precatenane removal.
2001,
Pubmed
,
Xenbase
Luke,
Quantitation of type II topoisomerase in oocytes and eggs of Xenopus laevis.
1989,
Pubmed
,
Xenbase
McGarry,
Geminin, an inhibitor of DNA replication, is degraded during mitosis.
1998,
Pubmed
,
Xenbase
Mikhailov,
Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway.
2004,
Pubmed
Niitsu,
The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
2002,
Pubmed
Roca,
Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.
1994,
Pubmed
Schvartzman,
A topological view of the replicon.
2004,
Pubmed
Shamu,
Sister chromatid separation in frog egg extracts requires DNA topoisomerase II activity during anaphase.
1992,
Pubmed
,
Xenbase
Skoufias,
Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase.
2004,
Pubmed
Tada,
Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin.
2001,
Pubmed
,
Xenbase
Toyoshima,
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
1994,
Pubmed
Trigueros,
Asymmetric removal of supercoils suggests how topoisomerase II simplifies DNA topology.
2004,
Pubmed
Tsutsui,
Involvement of DNA topoisomerase IIbeta in neuronal differentiation.
2001,
Pubmed
Wang,
Cellular roles of DNA topoisomerases: a molecular perspective.
2002,
Pubmed
